Whereas increased public awareness and early treatment of bladder cancer will save thousands of lives; Whereas more than 800,000 families in the United States live with bladder cancer; Whereas it is estimated that more than 82,290 people in the United States, or over 230 Americans every day, will be diagnosed with bladder cancer in 2023, including over 62,420 men and 19,870 women; Whereas it is estimated that bladder cancer will kill more than 16,710 Americans this year alone; Whereas the bladder cancer diagnosis rate is expected to increase by 1.35 percent in 2023, while many other forms of cancer are projected to decline; Whereas bladder cancer can directly impact all people, regardless of age, sex, and race; Whereas bladder cancer is among the top 7 most diagnosed cancers in the United States, and the top 4 most commonly diagnosed cancers for our honored veterans; Whereas, if diagnosed early, bladder cancer is highly treatable, but survivability rates decrease substantially with later detection; Whereas smoking and environmental or occupational exposure to carcinomic chemicals are the top causes of bladder cancer; Whereas studies have shown a higher level of bladder cancer in firefighters, veterans, and senior citizens than in the general public; Whereas bladder cancer symptoms, such as blood in the urine, are easily recognized, however, many Americans are unaware of the warning signs and often put off diagnostic testing and treatment; Whereas bladder cancer is known as one of the most expensive cancers to treat on a per patient basis and has a reoccurrence rate of approximately 50 to 80 percent, requiring lifelong surveillance; Whereas, while bladder cancer is more prevalent in men, women are commonly diagnosed at a later stage and face a worse prognosis even when diagnosed at the same stage as men; Whereas there have been limited significant breakthroughs in the past 30 years to advance the treatment of and move toward a cure for bladder cancer